Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-04-15EMA Authorised: Inovelon (rufinamide) — Eisai GmbH
EMA authorised Inovelon (rufinamide) by Eisai GmbH for epilepsy, following a decision on 28 November 2023.
-
FDA approval · 2025-04-15FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for divalproex sodium.
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) [Phase 2]
Phase 2 study update evaluating a diet-based treatment for Glucose Transporter Type 1 Deficiency Syndrome (GLUT1DS), with epilepsy as a co-o…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia [Phase 4]
Phase 4 trial evaluating brain regions and functional neuronal network characteristics during dexmedetomidine analgesia in epilepsy-related …
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Effectiveness of an Epilepsy Application for Self-management in Viet Nam [NA]
A completed clinical trial evaluating the effectiveness of an epilepsy self-management application in Vietnam.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: A Clinical Trial With a Self-controlled, Multicenter, Pediatric EEG Intelligent Analysis System to Assist in Diagnosis
A clinical trial is evaluating a self-controlled, multicenter EEG intelligent analysis system to assist in diagnosing pediatric epilepsy. Th…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings [NA]
A University of Utah study is recruiting to investigate autobiographical memory formation in real-world environments using multimodal record…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Implementation and Cost Evaluation of Project UPLIFT [NA]
This clinical trial update from Emory University describes a cost evaluation and implementation of Project UPLIFT for epilepsy. Recruitment …
-
FDA approval · 2025-04-04FDA Approved: LEVETIRACETAM — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Levetiracetam (generic) submitted by Fresenius Kabi USA, LLC, under ANDA090876.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
A clinical trial evaluates how concomitant diseases influence postoperative complication risk and aims to improve risk stratification; the s…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures [Phase 2]
An open-label Phase 2 trial to evaluate the efficacy and safety of PRAX-628 in adults with focal onset seizures or primary generalized epile…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE [NA]
A clinical trial evaluating long-term efficacy and safety of cerebellar-targeted transcranial magnetic stimulation for drug-resistant epilep…
-
FDA approval · 2025-03-27FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium (divalproex) by Aurobindo Pharma Limited. The approval pertains to the generic…
-
FDA approval · 2025-03-26FDA Approved: LEVETIRACETAM — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approved a supplemental application for LEVETIRACETAM INJECTION by Dr. Reddy's Laboratories, adding an injectable formulation of levetir…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia
A completed clinical trial evaluating epileptic activity in patients with Alzheimer's disease and Lewy body dementia.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
A clinical trial is currently recruiting to assess neuroprobing with TransOsseal Magnetic Stimulation for epilepsy.
-
FDA approval · 2025-03-21FDA Approved: PRIMIDONE — Supplemental Application (Carnegie Pharmaceuticals LLC)
FDA approved a supplemental application for Primidone (PRIMIDONE) from Carnegie Pharmaceuticals LLC, approving the supplemental submission f…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: READYorNot[TM] Brain-Based Disabilities Trial [NA]
A terminated McMaster University trial named READYorNot for brain-based disabilities has posted results across autism, cerebral palsy, epile…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy [NA]
This is a recruiting clinical trial in Paris studying social cognition networks and their alterations in patients with epilepsy, including t…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy
A pediatric epilepsy study evaluating white matter intensities has completed.
-
FDA approval · 2025-03-17FDA Approved: LEVETIRACETAM — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for LEVETIRACETAM by Civica, Inc. under ANDA 090981.
-
FDA approval · 2025-03-17FDA Approved: LEVETIRACETAM — Supplemental Application (Mylan Institutional LLC)
FDA granted a supplemental approval for LEVETIRACETAM (levetiracetam) by Mylan Institutional LLC under ANDA 203308. This action approves cha…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Neural Mechanisms of Spatial Representations Beyond the Self [NA]
A clinical trial sponsored by Boston University Charles River Campus is recruiting to study neural mechanisms of spatial representations bey…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Characterization of Neurocognitive Profiles in Neurodevelopmental Disorders and Epilepsy: a Transdiagnostic Approach
This clinical trial update describes a study on characterizing neurocognitive profiles across neurodevelopmental disorders and epilepsy usin…
-
FDA approval · 2025-03-13FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals' supplemental application for gabapentin to add a granule formulation.